Dexela Limited, the London-based company developing accurate and sensitive 3D imaging technology known as Tomosynthesis, focused initially on the early detection of breast cancer, is pleased to announce that it has raised more than £2.6 million ($5.2 million) through the issue of shares. The early detection of breast cancer using screening mammography significantly reduces mortality, […]
Less
More
Veran Medical Technologies Inc., a medical device start-up company, has secured $4.75M in venture capital and private financing to drive adoption of its IG4 delivery system for minimally invasive biopsy and ablation of cancer. Veran Medical Technologies is a privately held image-guided medical device company focused on developing the next standard of care for minimally […]
Confirma®, pioneer and leader in application-specific computer-aided-detection (CAD) for MRI, has raised a $17.5 million dollar Series C round. “Confirma has proven to be the leader in CAD for breast MRI with approximately a thousand systems installed throughout the world, assisting healthcare providers to meet the growing demand for breast MRI.” the company has developed […]
Israeli medical device start-up ActiViews Ltd. has raised $5 million. The company’s systems improve real-time guidance for computer tomography scanners (PET) and magnetic resonance imaging (MRI) devices for locating tumors for biopsies or removal. Currently, PETs and MRIs images are performed as slices and the images analyzed for subsequent invasive procedures. The images are costly, […]
Rubicor Medical Inc., a privately-held medical device company which develops and markets minimally invasive technologies for breast biopsy and tissue removal, announced today that it has entered into a $10 million loan agreement
U-Systems, Inc., the primary developer and leader in automated breast ultrasound systems, today announced the successful completion of a $16.5 million funding round led by Siemens Venture Capital . U-Systems designs, manufactures and markets automated ultrasound systems to assist healthcare providers in the early detection of breast cancer.
Naviscan PET Systems, Inc., a privately held company specializing in the development of high-resolution PET (Positron Emission Tomography) scanners, announced today that it has completed a $15 million Series C round of financing. “Naviscan’s PEM technology represents a significant step forward in the field of imaging and breast cancer,”
Sanarus Medical, a privately held company focused on developing and marketing minimally invasive devices for the diagnosis and treatment of breast tumors, announced today that it has closed a $15 million round of financing
Avantis Medical Systems, Inc. announced today that it has raised $12 million in its Series B round of financing. Avantis is developing the Third Eye Retroscope(TM), a new device for detection of colon cancers and polyps that are hidden from the view of a standard colonoscope.
NeoGuide Systems Inc., a developer of technology to prevent and treat colorectal cancer, today announced that it has raised $25 million in its Series C round of financing. NeoGuide is developing the NeoGuide Endoscopy System, a computer-assisted colonoscopy system designed to enhance physician control of the colonoscope and to eliminate looping, the principle reason why […]
Positron Emission Tomography (PET) scanners